Biomimetic Brain-Targeted Delivery of Esterified XAV939 for Treating Autism-Associated Social Deficits
Hanze Liu, Ya-Rong Wang, Mengmeng Wang, Tiantian Yu, Daozhou Liu, Jing Wang, Yang Gao, Yuanyiyang Hu, Hongyu Ma, Feng Gao, Shengxi Wu, Zhao Wei, Yazhou Wang · 2026
Read Biomimetic Brain-Targeted Delivery of Esterified XAV939 for Treating Autism-Associated Social Deficits by Hanze Liu, Ya-Rong Wang, Mengmeng Wang, Tiantian Yu, Daozhou Liu, Jing Wang, Yang Gao, Yuanyiyang Hu, Hongyu Ma, Feng Gao, Shengxi Wu, Zhao Wei, Yazhou Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13516923.txt.
Description
Liu and colleagues improved in 2026 a candidate drug for autism spectrum disorder so it can reach the brain. Their earlier work showed XAV939, a tankyrase blocker, eased social problems in two autism mouse models by damping Wnt and sugar-burning pathways. But the drug crosses the blood-brain barrier poorly and has low bioavailability. The team created ester versions, called prodrugs, and coated the best one in cell membrane for brain targeting.
Of three ester versions, one named XAV939-L1 kept the dual pathway blocking in cells and in neurons from Shank3b-mutant mice. Injected plainly, it improved social behaviour in those mice but caused liver side effects. Coating it in a hybrid neuron-astrocyte membrane greatly increased brain accumulation. The authors present membrane-coated prodrugs as a route to brain delivery for autism drug candidates that otherwise cannot cross.
Catalog record
| CREATOR | Hanze Liu, Ya-Rong Wang, Mengmeng Wang, Tiantian Yu, Daozhou Liu, Jing Wang, Yang Gao, Yuanyiyang Hu, Hongyu Ma, Feng Gao, Shengxi Wu, Zhao Wei, Yazhou Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |